Bertil Lindmark joins Almirall as R&D head

pharmafile | January 27, 2011 | Appointment | Research and Development |  Almirall, Bertil Lindmark, appointment, research and development 

Almirall has appointed Bertil Lindmark as executive director of R&D following the retirement of Dr Per-Olof Andersson.

Bertil joins the Spanish pharma company from AstraZeneca, where he served as VP and head clinical division at AstraZeneca Japan and before that as global therapy area clinical VP RITA (respiratory and inflammation therapy area).

He has 20 years’ experience in pharmaceutical R&D, with a focus on respiratory and extensive training in gastric diseases.